Nasdaq Income ETFs 2026: GPIQ Fee Advantage Sparks Debate
GPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...
Understanding which risk dominates can guide your allocation decisions. This comparison highlights when inflation worry or market dips matter more.
28,524 articlesGPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...
Tuesday’s market action centers on fresh analyst calls for Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Ve...
When a PayPal vice president sold a large block of stock, investors naturally wonder what it signals. This guide brea...
Singapore authorities have charged the former Hodlnaut CEO with allegedly misleading investors about the company’s ex...
As the IoT market expands, Synaptics is recalibrating its business to capture devices beyond smartphones. This deep d...
Bitcoin enters its first gapless CME trading week, a milestone that reshapes how price discovery and weekend hedging ...
Ripple’s XRP Ledger introduced a permissioned DEX and on-chain escrow tools aimed at banks and regulated firms, poten...
XRP tumbles to a 19-month low, but ripple etfs offer rare brightness with positive weekly inflows and steady growth i...
A fresh model built on bitcoin cycle data projects forecasts a pronounced downside path for BTC, with a December 2026...
As Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
In 2026, U.S. homebuilders are turning to AI-powered ERP to uncover margin leaks and streamline project handoffs as d...